The next step in systems biology: Simulating the temporospatial dynamics of molecular network

BioEssays

Volumn 26, Issue 1, 2004, Pages 68-72

  Zhu, Hao ^a   Huang, Sui ^b   Dhar, Pawan ^a  

^a BIOINFORMATICS INSTITUTE   (Singapore)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; COMPUTER; COMPUTER PROGRAM; COMPUTER SIMULATION; DATA BASE; GENE EXPRESSION REGULATION; GENOME; HUMAN; METHODOLOGY; MODEL; MOLECULAR DYNAMICS; MOLECULAR MODEL; PHYLOGENY; REGULATOR GENE; REVIEW; SYSTEM ANALYSIS; TIME;

ALGORITHMS; ANIMALS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; COMPUTERS; DATABASES; GENE EXPRESSION REGULATION; GENES, REGULATOR; HUMANS; MODELS, GENETIC; SOFTWARE; SYSTEMS ANALYSIS; SYSTEMS THEORY; TIME FACTORS;

EID: 0347004632     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10383     Document Type: Review

References (24)

1. Moret BME, et al. Toward new software for computational phylogenetics. Computer 2002;35:55-64.
2. Huang S. The practical problem of post-genomic biology. Nat Biotechnol 2000;18:471-472.
3. Vicsek T. Complexity: The bigger picture. Nature 2002;418:131.
4. Nurse P. Reductionism: The ends of understanding. Nature 1997;387:657.
5. Kitano H. Computational system biology. Nature 2002;420:206-210.
6. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signaling circuits in molecular interaction networks. Bioinformatics 2002;18:S233-S240.
7. Stelling J, Klamt S, Bettenbrock K, Schuster S, Gilles ED. Metabolic network structure determines key aspects of functionality and regulation. Nature 2002;420:190-193.
8. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL. The large-scale organization of metabolic networks. Nature 2000;407:651-654.
9. Maslov S, Sneppen K. Specificity and stability in topology of protein networks. Science 2002;296:910-913.
10. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical organization of modularity in metabolic network. Science 2002;297:1551-1555.
11. Kohn KW. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell 1999;10:2703-2734.
12. Patiag D, Qu X, Gray S, Idris I, Wilkes M, Seale JP, Donnelly R. Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro. J Endocrinol 2000;167:525-531.
13. Hucka M, et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003;19:524-531.
14. Tomita M. Whole-cell simulation: a grand challenge of the 21st century. Trends Biotechnol 2001;19:205-210.
15. Loew LM, Schaff JC. The Virtual Cell: a software environment for computational cell biology. Trends Biotechnol 2001;19:401-406.
16. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interaction. Proc Natl Acad Sci 2001;98:4569-4574.
17. Walhout AJM, Gubbels JM, Bernards R, van der Vliet PC, Timmers HTM. Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast 2000;17:88-94.
18. Hirata H, Yoshiura S, Ohtsuka T, Bessho Y, Harada T, Yoshikawa K, Kageyama R. Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop. Science 2002;298:840-843.
19. Meyts De P, et al. Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 1995;44(Suppl 4): 2-11.
20. Sebesta RW. Concepts of Programming Languages. Addison-Wesley; 2002.
21. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 2001;61:5697-5702.
22. Kmet LM, Cook LS, Magliocco AM. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 2003;97:389-404.
23. Kohn KW. Functional capabilities of molecular network components controlling the mammalian G 1/S cell cycle phase transition. Oncogene 1998;16:1065-1075.
24. Huang S. Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. Pharmacogenomics 2001;2:203-222.